Abstract
Intact parathyroid hormone (PTHi) has a relatively short half-life and levels fall significantly within 15 min of the successful excision of all the abnormal parathyroid glands during surgery for hyperparathyroidism. Monitoring this fall has been suggested as useful in decreasing the failure rate of neck explorations in parathyroid surgery. We have performed a comparative study of the use, during surgery for primary hyperparathyroidism, of routine frozen section with the recently available rapid assay for PTHi. The assay demonstrated a significant fall (P = 0.013) in the level of PTHi from a pre-excision mean of 26.66 pmol/l to 5.94 pmol/l 15 min after surgical excision. In all cases the level of PTHi fell to less than 30% of pre-excision levels by 30 min. However, while frozen section results were available in a mean time of 22 min after excision, the PTHi levels took a mean of 105 min. We conclude that during straightforward parathyroid surgery for primary hyperparathyroidism, the current assay does not offer any advantages over the already routine use of frozen section.
Full text
PDF



Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Auguste L. J., Attie J. N., Schnaap D. Initial failure of surgical exploration in patients with primary hyperparathyroidism. Am J Surg. 1990 Oct;160(4):333–336. doi: 10.1016/s0002-9610(05)80536-7. [DOI] [PubMed] [Google Scholar]
- Bergenfelz A., Nordén N. E., Ahrén B. Intraoperative fall in plasma levels of intact parathyroid hormone after removal of one enlarged parathyroid gland in hyperparathyroid patients. Eur J Surg. 1991 Feb;157(2):109–112. [PubMed] [Google Scholar]
- Curley I. R., Wheeler M. H., Aston J. P., Brown R. C., Weeks I., Woodhead J. S. Studies in patients with hyperparathyroidism using a new two-site immunochemiluminometric assay for circulating intact (1-84) parathyroid hormone. Surgery. 1987 Dec;102(6):926–931. [PubMed] [Google Scholar]
- Cusumano R. J., Mahadevia P., Silver C. E. Intraoperative histologic evaluation in exploration of the parathyroid glands. Surg Gynecol Obstet. 1989 Dec;169(6):506–510. [PubMed] [Google Scholar]
- Davies C., Demeure M. J., St John A., Edis A. J. Study of intact (1-84) parathyroid hormone secretion in patients undergoing parathyroidectomy. World J Surg. 1990 May-Jun;14(3):355–360. doi: 10.1007/BF01658526. [DOI] [PubMed] [Google Scholar]
- Endres D. B., Villanueva R., Sharp C. F., Jr, Singer F. R. Immunochemiluminometric and immunoradiometric determinations of intact and total immunoreactive parathyrin: performance in the differential diagnosis of hypercalcemia and hypoparathyroidism. Clin Chem. 1991 Feb;37(2):162–168. [PubMed] [Google Scholar]
- Flentje D., Schmidt-Gayk H., Fischer S., Stern J., Blind E., Buhr H., Herfarth C. Intact parathyroid hormone in primary hyperparathyroidism. Br J Surg. 1990 Feb;77(2):168–172. doi: 10.1002/bjs.1800770217. [DOI] [PubMed] [Google Scholar]
- Gaz R. D., Doubler P. B., Wang C. A. The management of 50 unusual hyperfunctioning parathyroid glands. Surgery. 1987 Dec;102(6):949–957. [PubMed] [Google Scholar]
- Goltzman D., Gomolin H., DeLean A., Wexler M., Meakins J. L. Discordant disappearance of bioactive and immunoreactive parathyroid hormone after parathyroidectomy. J Clin Endocrinol Metab. 1984 Jan;58(1):70–75. doi: 10.1210/jcem-58-1-70. [DOI] [PubMed] [Google Scholar]
- Heath H., 3rd, Hodgson S. F., Kennedy M. A. Primary hyperparathyroidism. Incidence, morbidity, and potential economic impact in a community. N Engl J Med. 1980 Jan 24;302(4):189–193. doi: 10.1056/NEJM198001243020402. [DOI] [PubMed] [Google Scholar]
- Lucas R. J., Welsh R. J., Glover J. L. Unilateral neck exploration for primary hyperparathyroidism. Arch Surg. 1990 Aug;125(8):982–985. doi: 10.1001/archsurg.1990.01410200040005. [DOI] [PubMed] [Google Scholar]
- Mundy G. R., Cove D. H., Fisken R. Primary hyperparathyroidism: changes in the pattern of clinical presentation. Lancet. 1980 Jun 21;1(8182):1317–1320. doi: 10.1016/s0140-6736(80)91783-3. [DOI] [PubMed] [Google Scholar]
- Nussbaum S. R., Thompson A. R., Hutcheson K. A., Gaz R. D., Wang C. A. Intraoperative measurement of parathyroid hormone in the surgical management of hyperparathyroidism. Surgery. 1988 Dec;104(6):1121–1127. [PubMed] [Google Scholar]
- Nussbaum S. R., Zahradnik R. J., Lavigne J. R., Brennan G. L., Nozawa-Ung K., Kim L. Y., Keutmann H. T., Wang C. A., Potts J. T., Jr, Segre G. V. Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia. Clin Chem. 1987 Aug;33(8):1364–1367. [PubMed] [Google Scholar]
- O'Brien D. P., Horgan P. G., Gough D. B., Skehill R., Grimes H., Given H. F. CA15-3: a reliable indicator of metastatic bone disease in breast cancer patients. Ann R Coll Surg Engl. 1992 Jan;74(1):9–12. [PMC free article] [PubMed] [Google Scholar]
- Ryan M. F., Jones S. R., Barnes A. D. Modification to a commercial immunoradiometric assay permitting intraoperative monitoring of parathyroid hormone levels. Ann Clin Biochem. 1990 Jan;27(Pt 1):65–68. doi: 10.1177/000456329002700113. [DOI] [PubMed] [Google Scholar]
- Stevenson J. C., Lynn J. A. Time to end a conservative treatment for mild hyperparathyroidism. Br Med J (Clin Res Ed) 1988 Apr 9;296(6628):1016–1017. doi: 10.1136/bmj.296.6628.1016-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Udén P., Aspelin P., Berglund J., Lilja B., Nyman U., Olsson L. E., Zederfeldt B. Preoperative localization in unilateral parathyroid surgery. A cost-benefit study on ultrasound, computed tomography and scintigraphy. Acta Chir Scand. 1990 Jan;156(1):29–35. [PubMed] [Google Scholar]
